Mazen Khodari
About Mazen Khodari
Mazen Khodari is the Senior Manager of Product Listing Agreements (Market Access & Pricing) at Bristol Myers Squibb in Montreal, Canada, with extensive experience in health economics, strategic partnerships, and market access.
Title
Mazen Khodari currently holds the position of Senior Manager, Product Listing Agreements (Market Access & Pricing) at Bristol Myers Squibb in the Montreal, Canada area. His role involves overseeing product listing agreements and guiding market access and pricing strategies.
Company
Bristol Myers Squibb is the current employer of Mazen Khodari, where he has worked since July 2011. At the company, he focuses on market access and pricing in the pharmaceutical sector, working with the pan-Canadian Pharmaceutical Alliance (PCPA) and various payers to negotiate drug listing agreements.
Previous Positions
Prior to his current role, Mazen Khodari worked at Sanofi as Manager, Business Insights from 2010 to 2011, and as Manager, Economic Analysis & Strategic Partnerships (Market Access & Pricing) from 2007 to 2010. He also held a position at Merck as Specialist - Health Economics & Outcomes Research from 2004 to 2007 and worked as a Consultant in various capacities from 1995 to 2004.
Education and Expertise
Mazen Khodari has a diverse educational background. He achieved a MSc in Statistics/Econometrics from Charles University (1989-1994), an MBA in Strategy, Finance, International Business from HEC Montréal (2001-2002), and completed a specialization in Pharmacoepidemiology and Pharmacoeconomics at McGill University (2005-2006). This education has equipped him with a strong foundation in strategic and financial analysis in the pharmaceutical field.
Specializations and Skills
Mazen Khodari specializes in health economics and outcomes research. He has considerable experience in strategic and financial analysis, public affairs, and payer strategy related to drug pricing and market access. His career has been marked by delivering innovative solutions for market access and pricing across multiple therapeutic areas.